Libya HIV Therapeutics Market Analysis

Libya HIV Therapeutics Market Analysis


$ 3999

The Libya HIV therapeutics market is expected to reach $xx Mn by 2030, up from $xx Mn in 2022, with a CAGR of xx% from 2022 to 2030. Local Players such as AlSahl Group, Afaaq Altamaiz, and Alfa Health Care dominate the HIV therapeutics market in Libya. The government policies, funding, and initiatives by international organizations like UNAIDS to manage HIV infections in the country propel the market. The HIV therapeutics market in Libya is divided into four segments: type, product, geography, end user, and distribution channel.

ID: IN10LYPH037 CATEGORY: Pharmaceuticals GEOGRAPHY: Libya AUTHOR: Dr. Vishwa Modhia

Buy Now

Libya HIV Therapeutics Market Analysis Summary

Between Egypt and Algeria in the northeastern corner of Africa lies Libya, a large desert nation consisting of roughly 6.5 Mn people. The Libya HIV therapeutics market is expected to reach $xx Mn by 2030, up from $xx Mn in 2022, with a CAGR of xx% from 2022 to 2030.

Libya had a 0.2% adult HIV/AIDS prevalence rate in 2021, with 9500 HIV cases, placing it in 96th place globally. According to the most recent WHO data published in 2020, the number of HIV/AIDS deaths in Libya reached 224, accounting for 0.89 % of all deaths. Libya ranks 92nd in the world with an age-adjusted death rate of 3.03 per 100,000 population.

The HIV prevalence among injecting drug users in Libya's capital, Tripoli, is an alarming 87 per cent. International humanitarian organizations, such as the United Nations Development Programme (UNDP) and GIZ, are constantly developing projects to help Libyans with their healthcare, and their collaboration with the Libyan government is critical.

Market Dynamics

Market Growth Drivers

Several non-governmental organisations (NGOs) are involved in HIV testing and counselling, as well as HIV medication distribution, including SOS AIDS Libya and the Association de lutte contre le sida (ALCS). UNAIDS (United Nations Programme on HIV/AIDS) is leading efforts to eliminate AIDS as a public health threat by 2030. UNAIDS works in Libya to raise HIV awareness and reduce stigma. As of 2021, 21,000 Libyan adults and children were infected with HIV. Unfortunately, this figure is rising. In Libya, UNAIDS is focusing on preventing HIV transmission from mother to child. It is also investing specifically in programmes that promote women's, girls, and young people's education, rights, and leadership. These factors may entice new entrants into the Libyan HIV therapeutics market.

Market Restraint

Libya has been ravaged by a violent and chaotic civil war since 2011, and many aspects of the country's society are in shambles. The main challenges confronting Libya's pharmaceutical industry are a lack of medicines and medical supplies. This is due to a variety of factors, one of which is that the industry is subject to a slew of complex rules and procedures that must be followed in order for the industry to function safely and efficiently: medicines registration, medicines selection, medicines procurement, medicines distribution, and medicines use. These factors could discourage new entrants into the Libyan HIV therapeutics market.

Competitive Landscape

Key Players

  • Alfa Health Care (LBY)
  • Afaaq Altamaiz (LBY)
  • AlSahl Group (LBY)
  • ViiV Healthcare
  • Bristol Myers Squibb
  • Merck & Co.
  • Gilead Sciences

Healthcare Regulations and Reimbursement Policies

The Libyan Food and Drug Control Centre (LFDC), the country's pharmaceutical and medical device regulatory agency, is in charge of HIV therapeutics regulation in Libya. The LFDC is in charge of registering, licencing, and inspecting all pharmaceutical products sold and distributed in the country, including HIV therapeutics. The LFDC is responsible for ensuring that all pharmaceutical products sold in Libya meet international quality and safety standards.

Access to HIV therapeutics is limited in Libya, and there is currently no formal reimbursement system in place. In providing adequate care and support for people living with HIV, the country has faced a number of challenges, including a lack of funding, limited access to medical supplies and equipment, and a shortage of trained healthcare professionals. Because there is no formal reimbursement system in Libya, most people who require HIV therapeutics must pay for them out of pocket. This has created significant difficulties for people living with HIV in the country, particularly those who cannot afford the high cost of these drugs.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

HIV Therapeutics Segmentation

By Types (Revenue, USD Billion):

  • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  • Coreceptor Antagonists
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
  • Protease Inhibitors (PIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 20 February 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up